Toll Free: 1-888-928-9744

Gaucher Disease Global Clinical Trials Review, H1, 2016

Published: Apr 20, 2016 | Pages: 84 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Gaucher Disease Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Gaucher Disease Global Clinical Trials Review, H1, 2016" provides an overview of Gaucher Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Gaucher Disease to Genetic Disorders Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Gaucher Disease to Genetic Disorders Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Gaucher Disease Therapeutics Clinical Trials 28 Prominent Drugs 30 Clinical Trial Profile Snapshots 31 Appendix 81 Abbreviations 81 Definitions 81 Research Methodology 82 Secondary Research 82 About GlobalData 83 Contact Us 83 Disclaimer 83 Source 84
List of Tables
Gaucher Disease Therapeutics, Global, Clinical Trials by Region, 2016* 6 Gaucher Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Gaucher Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Gaucher Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Gaucher Disease Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Gaucher Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Gaucher Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 15 Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, E7 Countries (%), 2016* 18 Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Gaucher Disease Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Gaucher Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Gaucher Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Gaucher Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Gaucher Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Gaucher Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Gaucher Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Gaucher Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30


List of Figures
Gaucher Disease Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Gaucher Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Gaucher Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Gaucher Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Gaucher Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Gaucher Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Gaucher Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, G7 Countries (%), 2016* 15 Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Gaucher Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Gaucher Disease to Genetic Disorders Clinical Trials, E7 Countries (%), 2016* 18 Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Gaucher Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Gaucher Disease Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Gaucher Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Gaucher Disease Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Gaucher Disease Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Gaucher Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Gaucher Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Gaucher Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Gaucher Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Gaucher Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 82

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global fluorotelomers market size is anticipated to be valued at USD 539.3 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing application scope in fire fighting systems owing to growing safety concerns is likely to dri

Read More...

Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable gover

Read More...

Global thermoplastic polyurethane (TPU) films market size is likely to be valued at USD 724.6 million by 2020; as per a new research report by Radiant Insights, Inc. Increase in lightweight plastics demand in order to achieve vehicle fuel efficiency

Read More...

Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliab

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify